IP Library Assignment 050751/0051
Patent Assignment
Reel/Frame 050751/0051

Security Interest

Recorded: 2019-10-17 Pages: 8
Assignor
Assignee
HAYFIN SERVICES LLP, AS COLLATERAL AGENT
ONE EAGLE PLACE, LONDON, SW1Y6AF, UNITED KINGDOM
Covered Properties (19)
Formulations Comprising Antisense Nucleotides to Connexins
Patent: 7,098,190 →
Application: 09/890,363 →
Antisense Compounds Targeted to Connexins and Methods of Use Thereof
Patent: 8,034,789 →
Application: 10/581,813 →
Publication: US 2007/0244062
Three Layer Artificial Tear Formulation
Patent: 7,758,883 →
Application: 10/688,539 →
Publication: US 2004/0142038
Formulations Comprising Antisense Nucleotides to Connexins
Patent: 7,615,540 →
Application: 11/510,280 →
Publication: US 2007/0060538
Formulations Comprising Antisense Nucleotides to Connexins
Patent: 7,919,474 →
Application: 11/510,496 →
Publication: US 2007/0078103
Formulations Comprising Antisense Nucleotides to Connexins
Patent: 7,879,811 →
Application: 11/510,498 →
Publication: US 2008/0221051
Formulations Comprising Antisense Nucleotides to Connexins
Patent: 8,314,074 →
Application: 12/592,668 →
Publication: US 2011/0065770
Ophthalmic Formulations of Cetirizine and Methods of Use
Patent: 9,254,286 →
Application: 12/724,128 →
Publication: US 2010/0240625
Ophthalmic Formulations of Cetirizine and Methods of Use
Patent: 8,569,273 →
Application: 12/888,117 →
Publication: US 2011/0257136
Anti-Connexin Compounds Targeted to Connexins and Methods of Use Thereof
Patent: 8,815,819 →
Application: 13/230,744 →
Publication: US 2012/0093768
Formulations Comprising Antisense Nucleotides to Connexins
Patent: 9,193,754 →
Application: 13/681,383 →
Publication: US 2013/0079388
Ophthalmic Formulations of Cetirizine and Methods of Use
Patent: 8,829,005 →
Application: 13/899,321 →
Publication: US 2013/0252971
Treatment of Fibrotic Conditions
Patent: 9,738,892 →
Application: 14/642,582 →
Publication: US 2015/0232842
Medical Devices
Patent: 9,561,311 →
Application: 14/715,282 →
Publication: US 2015/0297804
Channel Modulators
Application: 14/833,041 →
Publication: US 2016/0177298
Ophthalmic Formulations of Cetirizine and Methods of Use
Patent: 9,750,684 →
Application: 14/982,258 →
Publication: US 2016/0106666
Ophthalmic Formulations of Cetirizine and Methods of Use
Patent: 9,993,471 →
Application: 15/456,249 →
Publication: US 2017/0182035
Three layer artificial tear formulation
Application: 60/419,428 →
Ocular Lubricant Formulations
Application: 62/725,152 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 15, 2012
From: CODA THERAPEUTICS (NZ), LTD.
To: CODA THERAPEUTICS, INC.
Reel/Frame 029132/0021 →
Assignment of Assignor's Interest Oct 15, 2012
From: BECKER, DAVID L.; GREEN, COLIN R.
To: CODA THERAPEUTICS, LTD.
Reel/Frame 029131/0973 →
Assignment of Assignor's Interest Oct 15, 2012
From: UNIVERSITY COLLEGE LONDON
To: BECKER, DAVID L.; GREEN, COLIN R.
Reel/Frame 029131/0739 →
Assignment of Assignor's Interest Oct 15, 2012
From: BECKER, DAVID LAWRENCE; GREEN, COLIN RICHARD
To: UNIVERSITY COLLEGE LONDON
Reel/Frame 029131/0686 →
Assignment of Assignor's Interest Jan 9, 2013
From: CODA THERAPEUTICS (NZ) LIMITED
To: CODA THERAPEUTICS, INC.
Reel/Frame 029599/0577 →
Assignment of Assignor's Interest Jan 9, 2013
From: BECKER, DAVID L.; GREEN, COLIN R.
To: CODA THERAPEUTICS, LTD.
Reel/Frame 029599/0501 →
Security Interest Mar 6, 2015
From: CODA THERAPEUTICS, INC.
To: SQUARE 1 BANK
Reel/Frame 035102/0543 →
Change of Name Dec 29, 2015
From: ACIEX THERAPEUTICS, INC.
To: NICOX OPHTHALMICS, INC.
Reel/Frame 037396/0951 →
Change of Name Mar 4, 2016
From: ACIEX THERAPEUTICS, INC.
To: NICOX OPHTHALMICS, INC.
Reel/Frame 038007/0493 →
Assignment of Assignor's Interest May 24, 2016
From: ABELSON, MARK BARRY; CHAPIN, MATTHEW JONATHAN; GOMES, PAUL; MINNO, GEORGE
To: ACIEX THERAPEUTICS, INC.
Reel/Frame 038700/0598 →
Change of Name May 25, 2016
From: ACIEX THERAPEUTICS, INC.
To: NICOX OPHTHALMICS, INC.
Reel/Frame 038811/0257 →
Assignment of Assignor's Interest Feb 13, 2017
From: BECKER, DAVID L.; GREEN, COLIN R.; DUFT, BRADFORD J.
To: CODA THERAPEUTICS, INC.
Reel/Frame 041243/0504 →
Change of Name Jul 14, 2017
From: ACIEX THERAPEUTICS, INC.
To: NICOX OPHTHALMICS, INC.
Reel/Frame 043202/0908 →
Assignment of Assignor's Interest Jul 14, 2017
From: ABELSON, MARK BARRY; CHAPIN, MATTHEW JONATHAN; GOMES, PAUL; MINNO, GEORGE
To: ACIEX THERAPEUTICS, INC.
Reel/Frame 043008/0539 →
Change of Name Apr 2, 2018
From: CODA THERAPEUTICS, INC.
To: OCUNEXUS THERAPEUTICS, INC.
Reel/Frame 045812/0664 →
Change of Name Apr 2, 2018
From: CODA THERAPEUTICS, INC.
To: OCUNEXUS THERAPEUTICS, INC.
Reel/Frame 045811/0928 →
Security Interest Apr 9, 2018
From: OCUNEXUS THERAPEUTICS, INC. (F/K/A CODA THERAPEUTICS, INC.)
To: PACIFIC WESTERN BANK (AS SUCCESSOR IN INTEREST BY MERGER TO SQUARE 1 BANK)
Reel/Frame 045478/0638 →
Assignment of Assignor's Interest Jul 9, 2018
From: AQUEOUS PHARMA LIMITED
To: FOCUS LABORATORIES, INC.
Reel/Frame 046293/0160 →
Change of Name Oct 22, 2018
From: CODA THERAPEUTICS, INC.
To: OCUNEXUS THERAPEUTICS, INC.
Reel/Frame 047287/0842 →
Assignment of Assignor's Interest Oct 22, 2018
From: GREEN, COLIN RICHARD; BECKER, DAVID LAURENCE
To: CODATHERAPEUTICS (NZ) LIMITED
Reel/Frame 047268/0295 →
Assignment of Assignor's Interest Oct 22, 2018
From: CODATHERAPEUTICS (NZ) LIMITED
To: CODA THERAPEUTICS, INC.
Reel/Frame 047287/0859 →
Assignment of Assignor's Interest Nov 13, 2018
From: LAUX, WILDA; GREEN, COLIN
To: CODATHERAPEUTICS (NZ) LIMITED
Reel/Frame 047490/0227 →
Assignment of Assignor's Interest Dec 5, 2018
From: FOCUS LABORATORIES, INC.
To: EYEVANCE PHARMACEUTICALS LLC
Reel/Frame 047677/0824 →
Assignment of Assignor's Interest May 29, 2019
From: CODATHERAPEUTICS (NZ) LTD
To: CODA THERAPEUTICS, INC.
Reel/Frame 050305/0001 →
Assignment of Assignor's Interest May 29, 2019
From: GREEN, COLIN RICHARD; BECKER, DAVID LAURENCE
To: CODATHERAPEUTICS (NZ) LIMITED
Reel/Frame 049307/0726 →